151 related articles for article (PubMed ID: 36205905)
1. Quantification of Chromogranin A and Its Fragments in Biological Fluids.
Curnis F; Colombo B; Corti A
Methods Mol Biol; 2023; 2565():343-359. PubMed ID: 36205905
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of vasostatin-1, a chromogranin A fragment, are associated with carotid artery maximum stenosis: A pilot study.
Bachetti T; Ferrari Bardile A; Aloi TL; Colombo B; Assi E; Savino G; Vercelli A; Colombo R; Corti A
Int J Cardiol; 2017 Jun; 236():438-443. PubMed ID: 28190616
[TBL] [Abstract][Full Text] [Related]
3. Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers.
Corti A; Marcucci F; Bachetti T
Pflugers Arch; 2018 Jan; 470(1):199-210. PubMed ID: 29018988
[TBL] [Abstract][Full Text] [Related]
4. A new chromogranin A-dependent angiogenic switch activated by thrombin.
Crippa L; Bianco M; Colombo B; Gasparri AM; Ferrero E; Loh YP; Curnis F; Corti A
Blood; 2013 Jan; 121(2):392-402. PubMed ID: 23190532
[TBL] [Abstract][Full Text] [Related]
5. Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement.
Dallatomasina A; Gasparri AM; Colombo B; Sacchi A; Bianco M; Daniele T; Esposito A; Pastorino F; Ponzoni M; Marcucci F; Curnis F; Corti A
Cancer Res; 2019 Apr; 79(8):1925-1937. PubMed ID: 30796053
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation.
Mahata SK; Corti A
Ann N Y Acad Sci; 2019 Nov; 1455(1):34-58. PubMed ID: 31588572
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models.
Bianco M; Gasparri A; Generoso L; Assi E; Colombo B; Scarfò L; Bertilaccio MT; Scielzo C; Ranghetti P; Dondossola E; Ponzoni M; Caligaris-Cappio F; Ghia P; Corti A
Oncotarget; 2016 Jul; 7(27):41725-41736. PubMed ID: 27203389
[TBL] [Abstract][Full Text] [Related]
8. Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.
Corsello A; Di Filippo L; Massironi S; Sileo F; Dolcetta Capuzzo A; Gemma M; Carlucci C; Cusini C; Colombo B; Dallatomasina A; Franchi GM; Corti A; Manzoni MF
PLoS One; 2018; 13(5):e0196858. PubMed ID: 29723285
[TBL] [Abstract][Full Text] [Related]
9. Regulation of tumor growth by circulating full-length chromogranin A.
Curnis F; Dallatomasina A; Bianco M; Gasparri A; Sacchi A; Colombo B; Fiocchi M; Perani L; Venturini M; Tacchetti C; Sen S; Borges R; Dondossola E; Esposito A; Mahata SK; Corti A
Oncotarget; 2016 Nov; 7(45):72716-72732. PubMed ID: 27683038
[TBL] [Abstract][Full Text] [Related]
10. The chromogranin A
Rocca C; Grande F; Granieri MC; Colombo B; De Bartolo A; Giordano F; Rago V; Amodio N; Tota B; Cerra MC; Rizzuti B; Corti A; Angelone T; Pasqua T
Acta Physiol (Oxf); 2021 Apr; 231(4):e13570. PubMed ID: 33073482
[TBL] [Abstract][Full Text] [Related]
11. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function.
Pieroni M; Corti A; Tota B; Curnis F; Angelone T; Colombo B; Cerra MC; Bellocci F; Crea F; Maseri A
Eur Heart J; 2007 May; 28(9):1117-27. PubMed ID: 17389654
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A and the endothelial barrier function.
Corti A; Ferrero E
Curr Med Chem; 2012; 19(24):4051-8. PubMed ID: 22834794
[TBL] [Abstract][Full Text] [Related]
13. Chromogranin-A production and fragmentation in patients with Takayasu arteritis.
Tombetti E; Colombo B; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bozzolo EP; Tombolini E; Benedetti G; Godi C; Lanzani C; Rovere-Querini P; Del Maschio A; Ambrosi A; De Cobelli F; Sabbadini MG; Baldissera E; Corti A; Manfredi AA
Arthritis Res Ther; 2016 Aug; 18():187. PubMed ID: 27531191
[TBL] [Abstract][Full Text] [Related]
14. Recombinant N-terminal fragments of chromogranin-A modulate cardiac function of the Langendorff-perfused rat heart.
Cerra MC; De Iuri L; Angelone T; Corti A; Tota B
Basic Res Cardiol; 2006 Jan; 101(1):43-52. PubMed ID: 16151967
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A (CGA)-derived polypeptide (CGA
Luo L; Liu S; Zhang D; Wei F; Gu N; Zeng Y; Chen X; Xu S; Liu S; Xiang T
Peptides; 2020 Sep; 131():170297. PubMed ID: 32380199
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin A and the tumor microenvironment.
Corti A
Cell Mol Neurobiol; 2010 Nov; 30(8):1163-70. PubMed ID: 21080056
[TBL] [Abstract][Full Text] [Related]
17. Interactions of chromogranin A-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine.
Blois A; Holmsen H; Martino G; Corti A; Metz-Boutigue MH; Helle KB
Regul Pept; 2006 Mar; 134(1):30-7. PubMed ID: 16445995
[TBL] [Abstract][Full Text] [Related]
18. The chromogranin A-derived vasostatins: new players in the endocrine heart.
Tota B; Angelone T; Mazza R; Cerra MC
Curr Med Chem; 2008; 15(14):1444-51. PubMed ID: 18537621
[TBL] [Abstract][Full Text] [Related]
19. The interplay between chromogranin A-derived peptides and cardiac natriuretic peptides in cardioprotection against catecholamine-evoked stress.
Mazza R; Imbrogno S; Tota B
Regul Pept; 2010 Nov; 165(1):86-94. PubMed ID: 20594992
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotection against ischemia/reperfusion injury and chromogranin A-derived peptides.
Penna C; Tullio F; Perrelli MG; Mancardi D; Pagliaro P
Curr Med Chem; 2012; 19(24):4074-85. PubMed ID: 22834798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]